Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label Japan. Show all posts
Showing posts with label Japan. Show all posts
Wednesday, April 18, 2012

abstract: [Clinical aspects of familial ovarian cancer - current status and issues in Japan] (focus on brca)

›
Blogger's Note: the [ ] indicates translated version [Clinical aspects of familial ovarian cancer - current status and issues in Jap...
Friday, March 02, 2012

High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway - Japan

›
Abstract Purpose:   High-grade serous ovarian cancers are heterogeneous not only in terms of clinical outcome but also at the molecu...

abstract: Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumor in Japanese females: A population-based study from 1983 to 2007

›
 Blogger's Views: there are a number of interesting subjects here - Japan appears historically to have a higher rate of clear cell than...
Saturday, February 25, 2012

abstract: Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data

›
Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data : (defi...
Sunday, January 22, 2012

ASCO 2011 abstract: A North American population-based outcome for early-stage ovarian clear cell (stages 1-11) carcinoma (OCCC). - ASCO 2011 (including w/wo irradiation)

›
Abstract: Background: OCCC is regarded as having a poor outcome and being relatively treatment resistant. Recent Japanese data inste...
Saturday, January 21, 2012

abstract: A survey of the perspectives of patients who are seriously ill regarding end-of-life decisions in some medical institutions of Korea, China and Japan

›
Purpose "The debate about the end-of-life care decision is becoming a serious ethical and legal concern in the Far-Eastern countri...
Monday, January 09, 2012

Multinational Comparisons of Health Systems Data, 2011 - The Commonwealth Fund including link to 2011 patient care coordination (11 countries)

›
"International comparisons of health care systems offer valuable tools to health ministers, policymakers, and academics wishing to...
Sunday, March 20, 2011

Validation of the Histologic Grading for Ovarian Clear Cell Adenocarcinoma: A Retrospective Multi-institutional Study by the Japan Clear Cell Carcinoma Study Group

›
Abstract "Pathologic slides from 150 patients with clear cell adenocarcinoma from the collaborating institutions were reviewed indep...
Thursday, March 17, 2011

WHO | World Health Organization - radiation information/FAQ

›
WHO warns against self-medicating against radiation 17 March 2011 -- WHO is cautioning people concerned about the radiation issues in Japan...
Monday, March 14, 2011

(NCCN) Updated Ovarian Cancer Guidelines Offer a New Treatment Choice

›
Note: this refers to the Japanese study published 2010 of weekly Taxol - search blog for the original study and additional commentaries M...
Sunday, March 13, 2011

ABC News - Japan Earthquake: before and after photos (google earth)

›
Sun Mar 13, 2011 3:00pm AEDT Aerial photos taken over Japan have revealed the scale of devastation across dozens of suburbs and tens of tho...
Wednesday, January 26, 2011

Takeda Pharma, Millennium commence (AMG386) TRINOVA-1 Phase III cancer (ovarian) trial

›
Takeda Pharmaceutical and the Takeda Oncology Company: Millennium, have commenced TRINOVA-1 Phase III clinical trial on anti-cancer agent AM...
Saturday, April 24, 2010

Review and revision of guidelines for ovarian cancer in Japan (abstract)

›
A survey of members of the Japan Society of Gynecologic Oncology revealed that 93% of the members use the present Guideline for Ovarian Can...
Monday, April 12, 2010

commentary/Japanese study - Carbo/Taxol - Dose-Dense Chemotherapy for Ovarian Cancer - National Cancer Institute

›
"...Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard ...